Daniel A. Pollyea

24.9k citations
211 papers · 8.4k indexed · 7 hit papers · h-index 44
Topics
Acute Myeloid Leukemia Research (166 papers)Histone Deacetylase Inhibitors Research (50 papers)Chronic Myeloid Leukemia Treatments (42 papers)

In The Last Decade

Daniel A. Pollyea

200 papers receiving 8.4k citations

Hit Papers

Venetoclax combined with decitabine or azacitidine in...2013202620172021201820182018201820132505007501000

Peers

Daniel A. Pollyea
Comparison fields: 5 of 110
  • Hematology 6.0k
  • Molecular Biology 4.6k
  • Genetics 1.6k
  • Oncology 1.4k
  • Public Health, Environmental and Occupational Health 1.2k
Replace Michael Heuser with:
Michael Heuser Germany
Stéphane de Botton France
Jeffrey E. Lancet United States
Alexander E. Perl United States
Hitoshi Kiyoi Japan
B. Douglas Smith United States
Eva Hellström‐Lindberg Sweden
Maria Teresa Voso Italy
Tapan M. Kadia United States
Sylvie Castaigné France
Daniel A. Pollyea relative to Michael Heuser Germany Michael Heuser's profile →
Citations per field
00.5×1.5×1.9×
Michael Heuser · 1×
Citations per year

Countries citing papers authored by Daniel A. Pollyea

Since Specialization
Citations

This map shows the geographic impact of Daniel A. Pollyea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel A. Pollyea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel A. Pollyea more than expected).

Fields of papers citing papers by Daniel A. Pollyea

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel A. Pollyea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel A. Pollyea. The network helps show where Daniel A. Pollyea may publish in the future.

Co-authorship network of co-authors of Daniel A. Pollyea

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel A. Pollyea. A scholar is included among the top collaborators of Daniel A. Pollyea based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel A. Pollyea. Daniel A. Pollyea is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 0
4 5
5 5
6 6
7 75
8 19
9 27
10 104
11 60
12 103
13 86
14 24
15 20
16
Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemiabreakdown →
481
17 6
18 5
19 33
20 56

About Daniel A. Pollyea

Daniel A. Pollyea is a scholar working on Hematology, Genetics and Oncology, having authored 211 papers that have together received 8.4k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (166 papers), Histone Deacetylase Inhibitors Research (50 papers) and Chronic Myeloid Leukemia Treatments (42 papers). The work is most often cited by research in Hematology (6.0k citations), Genetics (1.6k citations) and Cancer Research (1.1k citations). Daniel A. Pollyea has collaborated with scholars based in United States, France and Canada. Frequent co-authors include Craig T. Jordan, Courtney D. DiNardo, Brian A. Jonas, Marina Konopleva, Andrew H. Wei, Hagop M. Kantarjian, Clayton A. Smith, Jalaja Potluri, Brett M. Stevens and Keith W. Pratz. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026